论文部分内容阅读
目的眼睑恶性肿瘤切除术后采用自体硬腭黏膜替代眼睑后层进行眼睑再造,并对其临床效果进行评价。方法1998年1月~2003年10月,对18例(18眼睑)患者行眼睑恶性肿瘤切除术后,局部旋转移位皮瓣或游离皮瓣联合自体硬腭黏膜替代眼睑后层的眼睑再造术。其中男10例,女8例,年龄35~67岁。18例均为重度眼睑缺损,其中眼睑全部缺损12例,2/3眼睑缺损6例。眼睑基底细胞癌10例,睑板腺癌6例,眼睑鳞状细胞癌2例。结果18眼睑术后外观及功能基本恢复正常,闭合完全,无内外翻。术后随访6个月~4年,平均3年2个月,眼睑形态及功能保持稳定,无植片感染及挛缩,无免疫排斥反应,无肿瘤复发。结论自体硬腭黏膜代替眼睑后层作眼睑恶性肿瘤切除术后的眼睑重建术,是一种简便易行、取材方便、术后并发症少、临床效果满意的眼睑再造术,硬腭黏膜优于传统的眼睑后层替代材料。
Objective Eyelid malignant tumor resection using autologous hard palate mucosa instead of eyelid posterior eyelid reconstruction, and evaluate its clinical effect. Methods From January 1998 to October 2003, eyelid reconstruction was performed in 18 patients with eyelid eyelid underwent eyelid resection after partial eyelid tumor resection with local rotational displacement flap or free flap combined with autologous hard palate mucosa. Including 10 males and 8 females, aged 35 to 67 years. Eighteen cases were severe eyelid defects, of which 12 cases had complete eyelid defect and 6 cases had 2/3 eyelid defect. Eyelid basal cell carcinoma in 10 cases, meibomian gland carcinoma in 6 cases, 2 cases of eyelid squamous cell carcinoma. Results eyelid appearance and function recovered to normal, completely closed, no valgus. The patients were followed up for 6 months to 4 years, with an average of 3 years and 2 months. The morphology and function of the eyelid remained stable with no allograft infection and contracture, no immune rejection and no tumor recurrence. Conclusions Autologous hard palate mucosa replaces the posterior eyelid for eyelid eyelid reconstruction after eyelid resection. It is an eyelid reconstructive technique which is simple and easy to draw, with less postoperative complications and satisfactory clinical results. The hard palate mucosa is superior to the traditional Eyelid replacement material.